The protection and success of TYLENOL® with Codeine in pediatric patients down below the age of eighteen have not been recognized. Patients need to be knowledgeable about the indicators of significant skin reactions, and use on the drug ought to be discontinued at the first physical appearance of skin rash https://wockusa.com/product-category/research-chemicals/